8-K
Current Report
Protalix BioTherapeutics, Inc. Filed Acc 0001144204-13-035540
Material agreement · Other events
- Item 1.01 Entry into a material definitive agreement
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading v348101_8k.htm…